Use of erythropoietin for the preventive or curative treatment of cardiac failure
US7335490B2 · kind B2 · utility
22Cited by
2References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 9, 2003 |
| Grant date | Feb 26, 2008 |
| Priority date | — |
| Expiry date | May 31, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are uses of erythropoietin, or a derivative or functional analogue thereof, for the production of a medicament for the preventive or curative treatment of patients suffering from, or at risk of suffering from, cardiac failure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.